CRVO
HealthcareCervoMed Inc.
$7.81
+$0.02 (+0.26%)
Jan 5, 2026
Price History (1Y)
Analysis
CervoMed Inc. is a biotechnology company within the healthcare sector, with a relatively small scale as indicated by its market capitalization of $72.26 million and revenue of $6.16 million. The company's financial health is concerning, with significant losses reported: net income stands at -$25,584,992 for the trailing 12 months, and free cash flow is also negative at -$15,325,722. Profit margins are severely impacted, with gross margin reaching -274.6% and operating margin hitting -2493.8%. Returns on equity and assets are similarly unfavorable, at -71.4% and -42.8%, respectively. The valuation context is somewhat complex due to the availability of certain metrics (e.g., P/E Ratio TTM). However, it's worth noting that revenue growth has declined by 83.4% year-over-year. Price to Book ratio stands at 2.78, while price to sales is 11.73. The company's beta is -6.25.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About CervoMed Inc.
CervoMed Inc., a a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule brain penetrant that inhibits p38 mitogen-activated protein kinase alpha. Neflamapimod has the potential to treat synaptic dysfunction, the reversible aspect of the underlying neurodegenerative processes that cause disease in DLB and certain other major neurological disorders. It is being evaluated in a Phase 2b study in patients with DLB. The company develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Visit website →Key Statistics
- Market Cap
- $72.26M
- P/E Ratio
- N/A
- 52-Week High
- $16.94
- 52-Week Low
- $1.92
- Avg Volume
- 80.33K
- Beta
- -6.25
Company Info
- Industry
- Biotechnology
- Exchange
- NCM
- Country
- United States
- Employees
- 15